Patterns of care, outcomes, and prognostics for transformed follicular lymphoma in the rituximab era. (PubMed, Haematologica) - Sep 25, 2026 - "Treatment following relapse from index therapy was commonly aggressive/salvage (often incorporating ASCT/CAR-T) in 44%. FLIPI (3-5), FL3A histology, IPI (4-5), ECOG >1, diagnosis to HT."
Journal • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • High-grade B-cell lymphoma • Lymphoma • Oncology
|
|
Amy A Ayers; Brad S Kahl; Brian K Link; Carla Casulo; Christopher R Flowers; Dai Chihara; Eric Mou; Izidore S Losso; James R Cerhan; Jason Romancik; Jonathan R Day; Loretta J Nastoupil; Matthew J Maurer; Melissa C Larson; Peter Martin; Thomas M Habermann; Umar Farooq; Urshila Durani; W Richard Burack; Yucai Wang
|